title: Influence of aging on the oxidative and conjugative metabolism of propranolol.
abstract: The influence of aging on the hepatic metabolism of propranolol, i.e. conjugation, side-chain oxidation and ring oxidation, was investigated in 32 in-patients aged 30 to 84 yrs. Plasma propranolol concentration and main urinary metabolites [propranolol glucuronide (PPLG), naphthoxylactic acid (NLA), and 4-hydroxypropranolol (40HP)] were determined after a single oral dose of 20 mg propranolol. There were significant correlations between age and 1) maximum propranolol concentration, 2) area under the plasma concentration-time curve, and 3) elimination half-life. The apparent oral clearance of propranolol was inversely correlated with age. Partial metabolic clearance (PMC) to 40HP (ring oxidation) and PMC to NLA (side-chain oxidation) were significantly correlated with age, while PMC to PPLG was not. These observations suggest that there are age-related reductions in two oxidizing capacities, while there is no significant influence of aging on the conjugating capacity. The age-related reduction in oral clearance of propranolol may be mainly caused by the decline in the capacity of two different oxidation pathways.
authors.affiliation: Department of Clinical Pharmacology and Therapeutics, Jichi Medical School, Tochigi, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Tateishi
authors.forename: A
authors.initials: A
authors.lastname: Fujimura
authors.forename: T
authors.initials: T
authors.lastname: Shiga
authors.forename: K
authors.initials: K
authors.lastname: Ohashi
authors.forename: A
authors.initials: A
authors.lastname: Ebihara
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000493:pharmacokinetics*; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000375:Aging / Q000378:metabolism*; D001711:Biotransformation; D005260:Female; D006207:Half-Life; D006801:Humans; D008297:Male; D008875:Middle Aged; D010084:Oxidation-Reduction; D011433:Propranolol / Q000493:pharmacokinetics*
chemical_list: D000319:Adrenergic beta-Antagonists; D011433:Propranolol